Novel Antisense Drug Shows Promise in Slowing Fatty Liver Disease
Wednesday, June 17, 2020 - 14:00
in Health & Medicine
Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine reports that inhibition of a key enzyme safely and effectively improved the health of persons with non-alcoholic fatty liver disease (NAFLD), a chronic metabolic disorder that affects hundreds of millions […]